News

COVID-19 : Basics of Drugs and Vaccines in progress

Any questions about the immune system, antibodies, and drug responses? Do post them in the comments section and we will help you understand better.

Read More

May 16, 2020

By : Anu Acharya

Boehringer Ingelheim, CDR-Life collaborate to develop antibody fragment-based therapeutics to treat blindness

The collaboration with CDR-Life is the second strategic partnership within a year for Boehringer Ingelheim in retinal diseases.

Read More

May 14, 2020

By : Team ABLE

Interim Favipiravir clinical trials show good results on COVID-19 patients in Russia

At least 60% of 40 patients in the study tested negative for COVID-19 after 5 days of Favipiravir. Russian agencies hope to start commercial supply of drug by Ma-end

Read More

May 14, 2020

By : Team ABLE

Glenmark initiates phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India

About 150 COVID-19 patients from over 10 leading government and private hospitals in India are being enrolled for the study.

Read More

May 13, 2020

By : Team ABLE

‘Nothing Very Unusual About SARS-CoV-2 In India That Makes It More Or Less Virulent’

We welcome feedback. Please write to respond@indiaspend.org. We reserve the right to edit responses for language and grammar.

Read More

May 13, 2020

By : Anoo Bhuyan, IndiaSpend

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights